Novocure Limited (NVCR) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Novocure Limited  (NASDAQ: NVCR)
 

Novocure Limited Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Novocure Limited's inventory turnover ratio, the ratio that measures Novocure Limited's ability to manage its supply chain, sequentially decreased to 3.98 in the third quarter 2026, but it does not raise any concerns as Novocure Limited continue to execute well, and the inventory turnover ratio remains above the average. Novocure Limited's average inventory processing period in the Sep 30 2026 quarter, has increased to 92 days, from 91 days, in the Jun 30 2026 quarter.

Within Healthcare sector 98 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 805 in the second quarter 2026, to 971.

NVCR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Novocure Limited Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVCR Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 3.84 % 5.01 % 10.11 % 17.17 % 0.02 %
Y / Y Cost of Sales Growth -0.45 % -0.88 % 1.06 % 25.97 % 26.45 %
Inventory Turnover Ratio (TTM) 3.98 4.02 4.08 4.17 4.11
NVCR's Total Ranking # 971 # 805 # 690 # 803 #
Average inventory processing period 92 91 89 87 89
Seq. Inventory Growth -3.83 % -2.84 % 5.71 % 5.13 % -2.75 %
Seq. Cost of Sales Growth 8.33 % 5.59 % -7.66 % -5.75 % 7.85 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 38
Healthcare Sector # 99
Overall Market # 971

Inventory Turnover Ratio Statistics
High Average Low
4.52 3.58 1.8
(Mar 31 2022)   (Mar 31 2017)



NVCR Company Profile >> Back to NVCR Efficiency Comparisons >> Compare NVCR Inventory Turnover Ratio to its Competitors

Financial Statements
Novocure Limited's Inventories $ 41 Millions Visit NVCR's Balance sheet
Novocure Limited's Cost of Revenues TTM $ 167 Millions Visit NVCR's Income Statement
What are NVCR's Sales? Visit NVCR's Sales by Segment

Other Inventory Turnover Ratios
Novocure Limited's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NVCR's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NVCR's Competitors
Inventory Turnover Ratio for NVCR's Suppliers
Inventory Turnover Ratio for NVCR's Customers

You may also want to know
NVCR's Sales Growth Rates NVCR's Pe Price to earnings ratio NVCR's Receivables Turnover Ratio NVCR's Stock Quote
NVCR's Net Income Growth Rates NVCR's Ps Price to Sales ratio NVCR's Sales per Employee NVCR's Asset Turnover Ratio
NVCR's Net Margin NVCR's Pb Price to Book ratio NVCR's Financial Strength Ratios NVCR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Tarsus Pharmaceuticals Inc   10.68 $ 49.325  Millions$ 5  Millions
Sotera Health Company  10.25 $ 558.509  Millions$ 54  Millions
Lantheus Holdings Inc   9.76 $ 604.826  Millions$ 62  Millions
Vanda Pharmaceuticals Inc   8.70 $ 14.704  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Novavax inc   7.03 $ 90.533  Millions$ 13  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Edap Tms Sa  6.14 $ 60.833  Millions$ 10  Millions
Transmedics Group Inc   5.70 $ 301.220  Millions$ 53  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Cryoport inc   4.60 $ 102.157  Millions$ 22  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions

Date modified: 2026-10-30T13:18:39+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.